468 related articles for article (PubMed ID: 23871888)
1. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
3. Protein Kinase B2 (PKB2/AKT2) Is Essential for Host Protection in CVB3-Induced Acute Viral Myocarditis.
Kim SH; Shin HH; Kim JH; Park JH; Jeon ES; Lim BK
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163412
[TBL] [Abstract][Full Text] [Related]
4. Roles of PAR1 and PAR2 in viral myocarditis.
Mackman N; Antoniak S
Thromb Res; 2014 May; 133 Suppl 1(0 1):S18-20. PubMed ID: 24759133
[TBL] [Abstract][Full Text] [Related]
5. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
6. Myeloid differentiation factor-88 contributes to TLR9-mediated modulation of acute coxsackievirus B3-induced myocarditis in vivo.
Riad A; Westermann D; Escher F; Becher PM; Savvatis K; Lettau O; Heimesaat MM; Bereswill S; Volk HD; Schultheiss HP; Tschöpe C
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2024-31. PubMed ID: 20228254
[TBL] [Abstract][Full Text] [Related]
7. Basic research on myocarditis: superb but unrequited.
Mason JW
J Am Coll Cardiol; 2013 Nov; 62(19):1746-7. PubMed ID: 23871883
[No Abstract] [Full Text] [Related]
8. PAR-1 contributes to the innate immune response during viral infection.
Antoniak S; Owens AP; Baunacke M; Williams JC; Lee RD; Weithäuser A; Sheridan PA; Malz R; Luyendyk JP; Esserman DA; Trejo J; Kirchhofer D; Blaxall BC; Pawlinski R; Beck MA; Rauch U; Mackman N
J Clin Invest; 2013 Mar; 123(3):1310-22. PubMed ID: 23391721
[TBL] [Abstract][Full Text] [Related]
9. Gene expression analysis during recovery process indicates the mechanism for innate immune injury and repair from Coxsackievirus B3-induced myocarditis.
Yao HL; Song J; Sun P; Song QQ; Sheng LJ; Chi MM; Han J
Virus Res; 2016 Feb; 213():314-321. PubMed ID: 26779987
[TBL] [Abstract][Full Text] [Related]
10. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP
Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-Specific Coxsackievirus and Adenovirus Receptor Deletion Enhances Macrophage M1 Polarity in CVB3-Induced Myocarditis.
Shin HH; Jeon ES; Lim BK
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982385
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor 4 protects mice from Coxsackievirus B3 and H1N1 influenza A virus infection.
Tatsumi K; Schmedes CM; Houston ER; Butler E; Mackman N; Antoniak S
Cell Immunol; 2019 Oct; 344():103949. PubMed ID: 31337508
[TBL] [Abstract][Full Text] [Related]
13. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy.
Westermann D; Savvatis K; Lindner D; Zietsch C; Becher PM; Hammer E; Heimesaat MM; Bereswill S; Völker U; Escher F; Riad A; Plendl J; Klingel K; Poller W; Schultheiss HP; Tschöpe C
Circulation; 2011 Nov; 124(19):2082-93. PubMed ID: 21986287
[TBL] [Abstract][Full Text] [Related]
14. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
16. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
17. Coxsackievirus B3-induced myocarditis: differences in the immune response of C57BL/6 and Balb/c mice.
Leipner C; Grün K; Schneider I; Glück B; Sigusch HH; Stelzner A
Med Microbiol Immunol; 2004 May; 193(2-3):141-7. PubMed ID: 14593475
[TBL] [Abstract][Full Text] [Related]
18. TLR3 deficiency induces chronic inflammatory cardiomyopathy in resistant mice following coxsackievirus B3 infection: role for IL-4.
Abston ED; Coronado MJ; Bucek A; Onyimba JA; Brandt JE; Frisancho JA; Kim E; Bedja D; Sung YK; Radtke AJ; Gabrielson KL; Mitzner W; Fairweather D
Am J Physiol Regul Integr Comp Physiol; 2013 Feb; 304(4):R267-77. PubMed ID: 23255589
[TBL] [Abstract][Full Text] [Related]
19. CARD9 mediates T cell inflammatory response in Coxsackievirus B3-induced acute myocarditis.
Sun C; Zhang X; Yu Y; Li Z; Xie Y
Cardiovasc Pathol; 2020; 49():107261. PubMed ID: 32771878
[TBL] [Abstract][Full Text] [Related]
20. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
